Cited 9 times in

Hepatocellular Carcinoma in the COVID-19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?

DC Field Value Language
dc.contributor.author성진실-
dc.date.accessioned2020-12-01T17:12:22Z-
dc.date.available2020-12-01T17:12:22Z-
dc.date.issued2020-06-
dc.identifier.issn1083-7159-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/180166-
dc.description.abstractThe COVID‐19 pandemic has presented an opportunity to evaluate current practices in cancer care. This letter to the editor focuses on one example, making the case for stereotactic body radiotherapy in Hepatocellular Carcinoma.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherAlphaMed Press-
dc.relation.isPartOfONCOLOGIST-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleHepatocellular Carcinoma in the COVID-19 Era: Primetime for Stereotactic Body Radiotherapy and a Lesson for the Future?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.googleauthorMarta Scorsetti-
dc.contributor.googleauthorKaryn A Goodman-
dc.contributor.googleauthorJinsil Seong-
dc.contributor.googleauthorMauro Loi-
dc.contributor.googleauthorFlorence Huguet-
dc.contributor.googleauthorLaura A Dawson-
dc.identifier.doi10.1634/theoncologist.2020-0416-
dc.contributor.localIdA01956-
dc.relation.journalcodeJ02415-
dc.identifier.eissn1549-490X-
dc.identifier.pmid32525607-
dc.contributor.alternativeNameSeong, Jin Sil-
dc.contributor.affiliatedAuthor성진실-
dc.citation.volume25-
dc.citation.number8-
dc.citation.startPagee1249-
dc.citation.endPagee1250-
dc.identifier.bibliographicCitationONCOLOGIST, Vol.25(8) : e1249-e1250, 2020-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.